Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
827.00    29.50 (3.70%)
Bid:
822.00
Ask:
825.00
Spread: 3.00 (0.365%)
Market Cap: £942.29m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Director/PDMR Shareholding

18 Nov 2019 07:00

RNS Number : 6602T
Fevertree Drinks PLC
18 November 2019
Β 

18 November 2019

Fevertree Drinks plc

Grant of Options

Fevertree Drinks plc (theΒ "Company") announces the grant of options over a total of 64,466 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company with an exercise price of 0.25 pence.

On 8th May 2019, the following options were issued to the Company's Executive Directors, pursuant to the Company's Long Term Incentive Plan ("LTIP"):

Name

Title

Number of share options granted

Performance period

Vesting period

Exercise price

Tim Warrillow

Chief Executive Officer

39,240

1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

Andy Branchflower

Finance Director

25,226

1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

Β 

The number of Ordinary Shares stated is the maximum number that could be issued to each Executive Director upon full satisfaction of the performance conditions attached to the 2019 awards.

Β 

The performance conditions are based on the achievement of targets linked to the Company's FY2021 turnover (as regards 75% of each award) and FY2021 adjusted EBITDA (as regards 25% of each award)

Β 

Taking account of previous grants, the total number of unvested options held by the Executive Directors detailed in this announcement, pursuant to the Company's LTIP, is as follows:

Β 

Tim Warrillow - 135,123 share options

Andy Branchflower - 75,395 share options

Β 

This includes the awards granted in 2017 and 2018, further details of which have been disclosed in the relevant Directors Remuneration Report.

Β 

For further information:

Β 

Fevertree Drinks plc

Β +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications & IR Director

Numis Securities - Nominated Adviser and Broker

+44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein

Β 

Investec Bank plc - Joint Broker

+44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson

Β 

Β 

Β 

Brunswick Group

+44 (0)20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud

Β 

Β 

Notes to Editors:

Β 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. Tim Warrillow

2. Andy Branchflower

2

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fevertree Drinks plc

b)

LEI

2138007AJRLHRVQZLD07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each

Β 

Identification code

GB00BRJ9BJ26

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

1. 0.25p

2. 0.25p

1. 39,240

2. 25,226

Β 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

8th May 2019

f)

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHDGBDBCSBBGCR
Date   Source Headline
11th Mar 20227:00 amRNSHolding(s) in Company
1st Mar 20229:46 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTotal Voting Rights
28th Jan 20224:32 pmRNSHolding(s) in Company
27th Jan 20227:00 amRNSFY21 Trading Update
4th Jan 20229:18 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSChange of Registered Office
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSBlock Listing Return
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
15th Sep 20217:00 amRNSFY21 Interim Results to 30 June 2021
1st Sep 20217:00 amRNSTotal Voting Rights
28th Jul 20214:53 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSHolding(s) in Company
20th Jul 20217:00 amRNSFY21 Half Year Pre-Close Trading update
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20215:35 pmRNSHolding(s) in Company
28th Jun 202111:23 amRNSHolding(s) in Company
4th Jun 20217:00 amRNSHolding(s) in Company
4th Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20212:26 pmRNSTotal Voting Rights
28th May 20217:00 amRNSBlock Listing Return
21st May 202111:21 amRNSGrant of Options
20th May 202112:37 pmRNSResult of Annual General Meeting
20th May 20217:00 amRNSAppointment of Non-Executive Director
20th May 20217:00 amRNSAGM Trading Update
4th May 20217:00 amRNSTotal Voting Rights
19th Apr 20214:15 pmRNS2020 Annual Report and Notice of AGM
19th Apr 202110:26 amRNSHolding(s) in Company
7th Apr 202111:55 amRNSTotal Voting Rights
7th Apr 20217:00 amRNSHolding(s) in Company
18th Mar 20217:00 amRNSFY20 Preliminary Results to 31 December 2020
1st Mar 20217:00 amRNSTotal Voting Rights
2nd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSFY20 Trading Update
4th Jan 20211:43 pmRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 20207:00 amRNSBlock Listing Return
27th Nov 20203:10 pmRNSHolding(s) in Company
2nd Nov 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
18th Sep 202010:30 amRNSHolding(s) in Company
15th Sep 20201:39 pmRNSDirector/PDMR Shareholding
11th Sep 20209:21 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSHalf-year Report
1st Sep 202011:07 amRNSTotal Voting Rights
4th Aug 20202:16 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.